Invivoscribe, INC.
At a glance
Employees100-499
In business sinceNot reported
HeadquartersSan Diego, CA
SAM.gov UEIR1EVMK8MEZS9
Invivoscribe develops molecular diagnostic instrumentation and assays for detecting mutations and measurable residual disease in hematologic malignancies. The company manufactures PCR-based and next-generation sequencing assays, digital PCR products, and software for clonality analysis, along with associated reagents and controls. It serves clinical laboratories and biopharma companies through both product sales and clinical laboratory services including screening and measurable residual disease testing.
Summarized from the company’s own website
What they make
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Invivoscribe, INC. | San Diego | CA | 100–499 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.